Researchers tackle vexing side effects of potent cancer drugs.
Where this comes from
- Record sourced from PubMed, PMID 36048951.
- Also identified by DOI 10.1126/science.ade6579.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Wider use of checkpoint inhibitor therapy spurs efforts to predict and treat immune complications.
Medical subject headings
- Immune Checkpoint Inhibitors
- Immune System Diseases
- Neoplasms